Software - Application
Compare Stocks
5 / 10Stock Comparison
SPNS vs GWRE vs VRNT vs NICE vs ACN
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Application
Software - Infrastructure
Software - Application
Information Technology Services
SPNS vs GWRE vs VRNT vs NICE vs ACN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Application | Software - Application | Software - Infrastructure | Software - Application | Information Technology Services |
| Market Cap | $2.43B | $11.70B | $1.24B | $5.62B | $112.34B |
| Revenue (TTM) | $564M | $1.34B | $894M | $3.01B | $72.11B |
| Net Income (TTM) | $64M | $189M | $61M | $529M | $7.68B |
| Gross Margin | 44.3% | 63.8% | 69.9% | 65.8% | 32.0% |
| Operating Margin | 13.7% | 6.8% | 8.6% | 20.7% | 14.8% |
| Forward P/E | 27.9x | 39.4x | 7.0x | 8.4x | 13.0x |
| Total Debt | $64M | $716M | $448M | $164M | $8.18B |
| Cash & Equiv. | $164M | $699M | $216M | $379M | $11.48B |
SPNS vs GWRE vs VRNT vs NICE vs ACN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | Dec 25 | Return |
|---|---|---|---|
| Sapiens Internation… (SPNS) | 100 | 184.7 | +84.7% |
| Guidewire Software,… (GWRE) | 100 | 210.5 | +110.5% |
| Verint Systems Inc. (VRNT) | 100 | 43.7 | -56.3% |
| NICE Ltd. (NICE) | 100 | 57.0 | -43.0% |
| Accenture plc (ACN) | 100 | 124.0 | +24.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SPNS vs GWRE vs VRNT vs NICE vs ACN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SPNS has the current edge in this matchup, primarily because of its strength in long-term compounding and sleep-well-at-night.
- 301.1% 10Y total return vs GWRE's 149.8%
- Lower volatility, beta 0.45, Low D/E 13.3%, current ratio 2.24x
- Beta 0.45, yield 1.3%, current ratio 2.24x
- Beta 0.45 vs VRNT's 1.25, lower leverage
GWRE is the clearest fit if your priority is growth exposure.
- Rev growth 22.6%, EPS growth 11.9%, 3Y rev CAGR 14.0%
- 22.6% revenue growth vs VRNT's -0.1%
Among these 5 stocks, VRNT doesn't own a clear edge in any measured category.
NICE is the #2 pick in this set and the best alternative if valuation efficiency is your priority.
- PEG 0.32 vs ACN's 1.44
- Lower P/E (8.4x vs 13.0x), PEG 0.32 vs 1.44
- 17.6% margin vs VRNT's 6.9%
ACN ranks third and is worth considering specifically for income & stability.
- Dividend streak 14 yrs, beta 0.80, yield 3.2%
- 3.2% yield, 14-year raise streak, vs VRNT's 1.6%, (2 stocks pay no dividend)
- 11.8% ROA vs VRNT's 2.8%, ROIC 26.8% vs 5.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 22.6% revenue growth vs VRNT's -0.1% | |
| Value | Lower P/E (8.4x vs 13.0x), PEG 0.32 vs 1.44 | |
| Quality / Margins | 17.6% margin vs VRNT's 6.9% | |
| Stability / Safety | Beta 0.45 vs VRNT's 1.25, lower leverage | |
| Dividends | 3.2% yield, 14-year raise streak, vs VRNT's 1.6%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +53.4% vs NICE's -43.4% | |
| Efficiency (ROA) | 11.8% ROA vs VRNT's 2.8%, ROIC 26.8% vs 5.3% |
SPNS vs GWRE vs VRNT vs NICE vs ACN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
SPNS vs GWRE vs VRNT vs NICE vs ACN — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ACN leads in 2 of 6 categories
SPNS leads 2 • GWRE leads 1 • NICE leads 1 • VRNT leads 0
Explore the data ↓Income & Cash Flow (Last 12 Months)
GWRE leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ACN is the larger business by revenue, generating $72.1B annually — 127.8x SPNS's $564M. NICE is the more profitable business, keeping 17.6% of every revenue dollar as net income compared to VRNT's 6.9%. On growth, GWRE holds the edge at +24.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $564M | $1.3B | $894M | $3.0B | $72.1B |
| EBITDAEarnings before interest/tax | $93M | $103M | $127M | $841M | $12.1B |
| Net IncomeAfter-tax profit | $64M | $189M | $61M | $529M | $7.7B |
| Free Cash FlowCash after capex | $72M | $310M | $118M | $569M | $12.5B |
| Gross MarginGross profit ÷ Revenue | +44.3% | +63.8% | +69.9% | +65.8% | +32.0% |
| Operating MarginEBIT ÷ Revenue | +13.7% | +6.8% | +8.6% | +20.7% | +14.8% |
| Net MarginNet income ÷ Revenue | +11.4% | +14.1% | +6.9% | +17.6% | +10.7% |
| FCF MarginFCF ÷ Revenue | +12.8% | +23.1% | +13.2% | +18.9% | +17.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +11.2% | +24.0% | -1.0% | +9.5% | +8.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -24.2% | +2.6% | -5.1% | -61.7% | +3.9% |
Valuation Metrics
NICE leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 9.6x trailing earnings, NICE trades at a 94% valuation discount to GWRE's 170.9x P/E. Adjusting for growth (PEG ratio), NICE offers better value at 0.36x vs SPNS's 1.69x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $2.4B | $11.7B | $1.2B | $5.6B | $112.3B |
| Enterprise ValueMkt cap + debt − cash | $2.3B | $11.7B | $1.5B | $5.4B | $109.0B |
| Trailing P/EPrice ÷ TTM EPS | 33.68x | 170.93x | 19.72x | 9.59x | 14.85x |
| Forward P/EPrice ÷ next-FY EPS est. | 27.85x | 39.38x | 7.00x | 8.38x | 13.00x |
| PEG RatioP/E ÷ EPS growth rate | 1.69x | — | 1.02x | 0.36x | 1.65x |
| EV / EBITDAEnterprise value multiple | 22.11x | 180.79x | 9.46x | 6.40x | 8.61x |
| Price / SalesMarket cap ÷ Revenue | 4.48x | 9.73x | 1.37x | 1.91x | 1.61x |
| Price / BookPrice ÷ Book value/share | 5.09x | 8.16x | 0.97x | 1.51x | 3.54x |
| Price / FCFMarket cap ÷ FCF | 33.63x | 39.66x | 8.75x | 7.99x | 10.33x |
Profitability & Efficiency
ACN leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
ACN delivers a 23.9% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $5 for VRNT. NICE carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to GWRE's 0.49x. On the Piotroski fundamental quality scale (0–9), SPNS scores 8/9 vs ACN's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +12.9% | +12.9% | +4.6% | +14.0% | +23.9% |
| ROA (TTM)Return on assets | +8.9% | +7.2% | +2.8% | +10.3% | +11.8% |
| ROICReturn on invested capital | +17.4% | +2.3% | +5.3% | +13.2% | +26.8% |
| ROCEReturn on capital employed | +16.9% | +2.3% | +5.9% | +16.1% | +24.9% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 7 | 7 | 7 | 5 |
| Debt / EquityFinancial leverage | 0.13x | 0.49x | 0.34x | 0.04x | 0.25x |
| Net DebtTotal debt minus cash | -$100M | $17M | $233M | -$216M | -$3.3B |
| Cash & Equiv.Liquid assets | $164M | $699M | $216M | $379M | $11.5B |
| Total DebtShort + long-term debt | $64M | $716M | $448M | $164M | $8.2B |
| Interest CoverageEBIT ÷ Interest expense | 228.41x | 388.85x | 8.24x | — | 40.67x |
Total Returns (Dividends Reinvested)
SPNS leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in SPNS five years ago would be worth $16,401 today (with dividends reinvested), compared to $4,070 for NICE. Over the past 12 months, SPNS leads with a +53.4% total return vs NICE's -43.4%. The 3-year compound annual growth rate (CAGR) favors SPNS at 26.2% vs NICE's -21.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | — | -26.2% | — | -17.2% | -29.3% |
| 1-Year ReturnPast 12 months | +53.4% | -35.1% | +13.8% | -43.4% | -39.5% |
| 3-Year ReturnCumulative with dividends | +100.9% | +78.2% | -39.3% | -50.8% | -25.4% |
| 5-Year ReturnCumulative with dividends | +64.0% | +41.7% | -55.8% | -59.3% | -29.2% |
| 10-Year ReturnCumulative with dividends | +301.1% | +149.8% | -37.1% | +46.1% | +90.1% |
| CAGR (3Y)Annualised 3-year return | +26.2% | +21.2% | -15.3% | -21.1% | -9.3% |
Risk & Volatility
SPNS leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
SPNS is the less volatile stock with a 0.45 beta — it tends to amplify market swings less than VRNT's 1.25 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SPNS currently trades 99.8% from its 52-week high vs GWRE's 50.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.45x | 0.50x | 1.25x | 0.48x | 0.80x |
| 52-Week HighHighest price in past year | $43.52 | $272.60 | $22.84 | $180.61 | $325.71 |
| 52-Week LowLowest price in past year | $26.14 | $115.57 | $16.23 | $90.70 | $172.52 |
| % of 52W HighCurrent price vs 52-week peak | +99.8% | +50.8% | +89.8% | +51.3% | +55.4% |
| RSI (14)Momentum oscillator 0–100 | 69.6 | 49.7 | 68.4 | 40.1 | 41.9 |
| Avg Volume (50D)Average daily shares traded | 0 | 1.3M | 0 | 635K | 5.6M |
Analyst Outlook
ACN leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: SPNS as "Hold", GWRE as "Buy", VRNT as "Hold", NICE as "Buy", ACN as "Buy". Consensus price targets imply 77.1% upside for GWRE (target: $245) vs -12.5% for SPNS (target: $38). For income investors, ACN offers the higher dividend yield at 3.24% vs SPNS's 1.30%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $38.00 | $245.17 | $32.57 | $148.38 | $299.92 |
| # AnalystsCovering analysts | 10 | 26 | 16 | 23 | 53 |
| Dividend YieldAnnual dividend ÷ price | +1.3% | — | +1.6% | — | +3.2% |
| Dividend StreakConsecutive years of raises | 1 | — | 0 | 0 | 14 |
| Dividend / ShareAnnual DPS | $0.57 | — | $0.32 | — | $5.85 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +5.8% | +8.8% | +4.1% |
ACN leads in 2 of 6 categories (Profitability & Efficiency, Analyst Outlook). SPNS leads in 2 (Total Returns, Risk & Volatility).
SPNS vs GWRE vs VRNT vs NICE vs ACN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SPNS or GWRE or VRNT or NICE or ACN a better buy right now?
For growth investors, Guidewire Software, Inc.
(GWRE) is the stronger pick with 22. 6% revenue growth year-over-year, versus -0. 1% for Verint Systems Inc. (VRNT). NICE Ltd. (NICE) offers the better valuation at 9. 6x trailing P/E (8. 4x forward), making it the more compelling value choice. Analysts rate Guidewire Software, Inc. (GWRE) a "Buy" — based on 26 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SPNS or GWRE or VRNT or NICE or ACN?
On trailing P/E, NICE Ltd.
(NICE) is the cheapest at 9. 6x versus Guidewire Software, Inc. at 170. 9x. On forward P/E, Verint Systems Inc. is actually cheaper at 7. 0x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: NICE Ltd. wins at 0. 32x versus Accenture plc's 1. 44x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — SPNS or GWRE or VRNT or NICE or ACN?
Over the past 5 years, Sapiens International Corporation N.
V. (SPNS) delivered a total return of +64. 0%, compared to -59. 3% for NICE Ltd. (NICE). Over 10 years, the gap is even starker: SPNS returned +301. 1% versus VRNT's -37. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SPNS or GWRE or VRNT or NICE or ACN?
By beta (market sensitivity over 5 years), Sapiens International Corporation N.
V. (SPNS) is the lower-risk stock at 0. 45β versus Verint Systems Inc. 's 1. 25β — meaning VRNT is approximately 175% more volatile than SPNS relative to the S&P 500. On balance sheet safety, NICE Ltd. (NICE) carries a lower debt/equity ratio of 4% versus 49% for Guidewire Software, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — SPNS or GWRE or VRNT or NICE or ACN?
By revenue growth (latest reported year), Guidewire Software, Inc.
(GWRE) is pulling ahead at 22. 6% versus -0. 1% for Verint Systems Inc. (VRNT). On earnings-per-share growth, the picture is similar: Guidewire Software, Inc. grew EPS 1192% year-over-year, compared to 6. 2% for Accenture plc. Over a 3-year CAGR, GWRE leads at 14. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SPNS or GWRE or VRNT or NICE or ACN?
NICE Ltd.
(NICE) is the more profitable company, earning 20. 8% net margin versus 5. 8% for Guidewire Software, Inc. — meaning it keeps 20. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NICE leads at 21. 9% versus 3. 4% for GWRE. At the gross margin level — before operating expenses — VRNT leads at 71. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SPNS or GWRE or VRNT or NICE or ACN more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, NICE Ltd. (NICE) is the more undervalued stock at a PEG of 0. 32x versus Accenture plc's 1. 44x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Verint Systems Inc. (VRNT) trades at 7. 0x forward P/E versus 39. 4x for Guidewire Software, Inc. — 32. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GWRE: 77. 1% to $245. 17.
08Which pays a better dividend — SPNS or GWRE or VRNT or NICE or ACN?
In this comparison, ACN (3.
2% yield), VRNT (1. 6% yield), SPNS (1. 3% yield) pay a dividend. GWRE, NICE do not pay a meaningful dividend and should not be held primarily for income.
09Is SPNS or GWRE or VRNT or NICE or ACN better for a retirement portfolio?
For long-horizon retirement investors, Sapiens International Corporation N.
V. (SPNS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 45), 1. 3% yield, +301. 1% 10Y return). Both have compounded well over 10 years (SPNS: +301. 1%, VRNT: -37. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SPNS and GWRE and VRNT and NICE and ACN?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: SPNS is a small-cap quality compounder stock; GWRE is a mid-cap high-growth stock; VRNT is a small-cap quality compounder stock; NICE is a small-cap deep-value stock; ACN is a mid-cap deep-value stock. SPNS, VRNT, ACN pay a dividend while GWRE, NICE do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.